Progesterone does not thicken the uterine lining. That job belongs to estrogen. What progesterone does is equally important but fundamentally different: it transforms the lining from a growing layer of cells into a mature, receptive structure capable of supporting a pregnancy. This distinction matters whether you’re trying to conceive, undergoing fertility treatment, or taking hormone therapy.
What Actually Thickens the Lining
During the first half of your menstrual cycle (roughly days 1 through 14 in a typical 28-day cycle), estrogen drives rapid cell division in the endometrium. This is the proliferative phase, and it’s when the lining physically grows thicker, building up layers of tissue, glands, and blood vessels. Estrogen triggers specific growth-related genes, including those involved in insulin-like growth factor signaling, that push cells to multiply.
After ovulation around day 14, the ovary begins producing progesterone from a temporary structure called the corpus luteum. Progesterone then does something counterintuitive: it actually stops the estrogen-driven growth. It reduces the number of estrogen receptors in the lining and speeds up the breakdown of active estrogen into a weaker form. Rather than adding more cells, progesterone shifts the lining into a completely different mode.
What Progesterone Does Instead
Once progesterone levels rise, the endometrium enters its secretory phase. The glands that estrogen built begin producing nutrient-rich secretions, including glycogen, that would nourish an embryo in its earliest days. The stromal cells (the connective tissue of the lining) start a process called decidualization, transforming from ordinary fibroblasts into specialized decidual cells. These cells create an entirely new tissue environment: one that regulates immune activity, builds new blood vessel networks, and produces molecules that allow communication between a mother’s body and an implanting embryo.
Think of it this way: estrogen builds the house, and progesterone furnishes it and makes it livable. On ultrasound, the lining may not get measurably thicker during the secretory phase. It may even appear slightly thinner or change in texture. But structurally, it’s becoming far more complex and functional. A thick lining that hasn’t been properly transformed by progesterone is not a receptive lining.
Why Lining Thickness Still Matters
In fertility treatment, clinicians measure endometrial thickness by ultrasound before embryo transfer. The evidence points to a clear threshold: pregnancy rates drop sharply when the lining is below 7 mm. In one large study, clinical pregnancy rates were 25.5% when the lining was 7 mm or thinner, 52.1% between 7 and 14 mm, and 63.5% above 14 mm. A cutoff of about 9 mm predicted pregnancy outcomes with both high sensitivity and specificity. Thicker linings, even above 14 mm, did not appear to hurt outcomes.
But thickness alone tells only part of the story. That measurement largely reflects what estrogen accomplished in the proliferative phase. The quality and receptivity of the lining, which determine whether an embryo can actually implant and thrive, depend on adequate progesterone exposure during the days that follow.
Progesterone in IVF and Fertility Treatment
During IVF cycles, the medications used to prevent premature ovulation also suppress your ovary’s ability to produce progesterone naturally. To compensate, progesterone supplementation typically begins on the day of egg retrieval. This gives the lining time to undergo the secretory changes needed before embryo transfer.
Progesterone for IVF can be given as an intramuscular injection, or through the vagina as a suppository, gel, or tablet. Studies show no meaningful difference in pregnancy rates between these routes. One important exception: oral progesterone pills do not work well for this purpose because the stomach does not absorb enough of the hormone to adequately support the lining. If pregnancy occurs, supplementation usually continues through the first trimester until the placenta takes over progesterone production.
How Progesterone Protects Against Overgrowth
When estrogen acts on the lining without progesterone to counterbalance it, cells keep dividing unchecked. This condition, called endometrial hyperplasia, is a precursor to endometrial cancer. It commonly occurs in situations where progesterone is low or absent: irregular ovulation, polycystic ovary syndrome, obesity (fat tissue produces estrogen), or taking estrogen-only hormone therapy after menopause.
Progesterone and synthetic progestins treat hyperplasia by reactivating the brakes on cell growth and triggering decidualization, which leads to thinning of the overgrown lining. Treatment results are strong. Studies show that 80 to 90% of patients with hyperplasia without atypical cells see their lining return to normal within three to six months of progestin treatment. A large UK study using a progestin-releasing intrauterine device reported a 90% regression rate after two years. Even in cases with more concerning cellular changes, progestin therapy achieved complete response in about 82% of patients.
This is why hormone replacement therapy for menopause almost always includes a progestogen alongside estrogen for anyone who still has a uterus. The progestogen component exists specifically to prevent the estrogen from driving uncontrolled endometrial growth.
Progesterone’s Role in Early Pregnancy
If an embryo implants, progesterone’s work is just beginning. The decidualized lining becomes the decidua, a specialized organ that serves as the interface between mother and developing pregnancy. This tissue does far more than provide a cushion. It produces antioxidant enzymes that protect against oxidative stress, regulates local estrogen concentrations through its own enzyme activity, and recruits a specific population of immune cells called uterine natural killer cells. Despite the name, these cells are not attacking anything. They help remodel the blood vessels that will eventually supply the placenta, ensuring adequate blood flow to the growing embryo.
The decidua ultimately forms three distinct regions, each with a different relationship to the placenta and the uterine wall. This entire structure depends on progesterone. Without sustained progesterone signaling, the lining breaks down and sheds, which is exactly what happens during a normal period when the corpus luteum stops producing progesterone in a cycle where pregnancy did not occur.